Literature DB >> 1159624

Derivation of general equations for linear mammillary models when the drug is administered by different routes.

D P Vaughan, A Trainor.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1159624     DOI： 10.1007/bf01067909

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man.

Authors:  A H Beckett; J A Salmon
Journal:  J Pharm Pharmacol       Date:  1972-02       Impact factor: 3.765

2.  Comparative pharmacokinetics of coumarin anticoagulants. IV. Application of a three-compartmental model to the analysis of the dose-dependent kinetics of bishydroxycoumarin elimination.

Authors:  R Nagashima; G Levy; R A O'Reilly
Journal:  J Pharm Sci       Date:  1968-11       Impact factor: 3.534

3.  Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters.

Authors:  E R Garrett; H J Lambert
Journal:  J Pharm Sci       Date:  1973-04       Impact factor: 3.534

4.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics.

Authors:  L Z Benet
Journal:  J Pharm Sci       Date:  1972-04       Impact factor: 3.534

5.  Use of general partial fraction theorem for obtaining inverse laplace transforms in pharmacokinetic analysis.

Authors:  L Z Benet; J S Turi
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

6.  Pharmacokinetic basis for the influence of route of administration on the area under the plasma concentration-time curve.

Authors:  M Gibaldi; S Feldman
Journal:  J Pharm Sci       Date:  1969-12       Impact factor: 3.534

7.  Some pharmacokinetic aspects of 5-(dimethylriazeno)-imidazole-4-carboxamide in the dog.

Authors:  T L Loo; B B Tanner; G E Housholder; B J Shepard
Journal:  J Pharm Sci       Date:  1968-12       Impact factor: 3.534

8.  Multicompartment pharmacokinetic models and pharmacologic effects.

Authors:  G Levy; M Gibaldi; W J Jusko
Journal:  J Pharm Sci       Date:  1969-04       Impact factor: 3.534

9.  Pharmacokinetics of pentazocine in the rhesus monkey.

Authors:  K A Pittman; G A Portmann
Journal:  J Pharm Sci       Date:  1974-01       Impact factor: 3.534

10.  An analysis of the inter-subject variation in the metabolism of pentazocine.

Authors:  D P Vaughan; A H Beckett
Journal:  J Pharm Pharmacol       Date:  1974-10       Impact factor: 3.765
View more
  4 in total

1.  Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Number of exponential terms describing the solution of an N-compartmental mammillary model: vanishing exponentials.

Authors:  D P Vaughan; M J Dennis
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

3.  Model independent derivation of general equations for the "first-pass" effect and extra-hepatic drug elimination.

Authors: 
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 4.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.